Due to the significant effect of the Akt signaling pathway on AD deterioration, understanding the dynamics of AKT1 upregulation could therefore provide critical insights into developing targeted therapies as we suggest with the inhibitor molecules that we identified in this article. This evidence concerns the gene AKT1 and Alzheimer disease.